SUMO1 regulates post-infarct cardiac repair based on cellular heterogeneity.

"Declaration of competing interest The authors declare that there are no conflicts of interest. Declaration of competing interest"

"The authors gratefully acknowledge Xiaohui Fan, PhD (Pharmaceutical Informatics Institute, College of Pharmaceutical Sciences, Zhejiang University, China) for assisting with snRNA-seq experiments. The authors thank Wei Yang, PhD (Duke University Medical Center, USA) for providing SUMO1−/− mice. This study was supported by the Innovation Team and Talents Cultivation Program of National Administration of Traditional Chinese Medicine (Grant No.: ZYYCXTD-D-202207), the National Natural Science Foundation of China (Grant Nos.: 82270304, 81774050, and 81901526), the Tianjin Special Project of New Generation Artificial Intelligence Technology (Project No.: 18ZXZNSY00260), and the Ministry of Education of People's Republic of China “Program for Innovative Research Team in University” (Project No.: IRT_16R54)."